Cannabis (freepik photo)
Sheikh Medical received from the rabbinical body, Efrati Shlita, a kosher certificate for most of its products, as well as confirmation that most of the company’s products meet the strict requirements of strictly kosher regarding the year of the shemita.
The approval was given following the company’s early preparations and adjustments it made from the month of Elul 5721 (August 2021), before the beginning of the current Hebrew year, in the growing facilities and growing processes carried out by it, accompanied by strictly kosher representatives headed by the rabbinical body.
More in-
Receipt of the shemita approval and training certificate for the company’s products, as part of its focus on its activities in the Israeli market, may expose and make the company’s products accessible to new target audiences, with an emphasis on the traditional ultra-Orthodox market. A training certificate and approval of the shemita will allow the religious audience to use the company’s products even if they were grown during the shemita year, and accordingly, the company estimates that there is potential to expand its sales to this target audience. It should be noted that to the best of the company’s knowledge, a company that has not complied with the shmita rules since the beginning of the current Hebrew year, will not be able to obtain a shmita permit, and accordingly the company has an advantage in this regard.
Sheikh Medical Group, a company owned by the Sarid family (about 64%), is a pioneer of medical cannabis in Israel. Sheikh has been growing and developing solutions in the field of medical cannabis since 2008 under uncompromising standards and provides a cure for tens of thousands of patients across the country. Sheikh currently owns growing facilities on an area of 14 dunams and maintains collaborations with other farms in Israel and abroad in order to increase production capacity for the Israeli and international market.
More in-
The Medical Discourse strategy strives for direct and unmediated contact with the final Israeli customer. Accordingly, the company places infrastructure along the value chain in order to address the growing consumer audience in the market alongside readiness for legalization.
The company owns a number of pharmacies with a cannabis issuance license and intends to establish a pharmacy network while continuing cooperation with all relevant pharmacies. In addition, the company has a supportive customer service system. The company has leading and popular brands, its products are known for their quality and efficiency. Marmalade, Black, Dutch, Kush-Dan, The Elements Series and The Biblical Series. The company is prepared for the possible regulatory changes that the company estimates are expected to benefit it.
Sheikh Medical is a leader in research and development and holds over 500 genetic lines. The company recently received approval for the registration of 15 strains. Sheikh Medical Group conducts research in the field of medical cannabis in collaboration with research institutes, leading universities and international companies, and is a partner in a number of projects dealing with scientific activity, genetic research and technology development in the field of medical cannabis.
Comments on the article(0):
Your response has been received and will be published subject to system policies.
Thanks.
For a new response
Your response was not sent due to a communication problem, please try again.
Return to comment